{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:08:57Z","timestamp":1790140137949,"version":"4.0.1"},"reference-count":58,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s315174","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T02:01:04Z","timestamp":1733968864000},"page":"5985-5996","source":"Crossref","is-referenced-by-count":14,"title":["Profile of Ofatumumab in the Treatment of Multiple Sclerosis: Design, Development and Place in Therapy"],"prefix":"10.2147","volume":"Volume 18","author":[{"given":"Zeinab","family":"Awada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaff","family":"Harel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"a028928","DOI":"10.1101\/cshperspect.a028928","volume":"8","author":"Klineova","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007035","volume":"92","author":"Wallin","year":"2019","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1001\/jamaneurol.2023.1135","volume":"80","author":"Hittle","year":"2023","journal-title":"JAMA Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ana.25927","volume":"89","author":"Comi","year":"2021","journal-title":"Ann Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s40120-023-00518-0","volume":"12","author":"Hauser","year":"2023","journal-title":"Neurol Ther"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00401-017-1744-4","volume":"134","author":"van Nierop","year":"2017","journal-title":"Acta Neuropathol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3390\/brainsci10100758","volume":"10","author":"Florou","year":"2020","journal-title":"Brain Sci"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00415-023-12007-3","volume":"271","author":"Delgado","year":"2024","journal-title":"J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1004795","DOI":"10.3389\/fimmu.2023.1004795","volume":"14","author":"de S\u00e8ze","year":"2023","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"102787","DOI":"10.1016\/j.msard.2021.102787","volume":"49","author":"Cotchett","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s40265-024-02011-w","volume":"84","author":"Carlson","year":"2024","journal-title":"Drugs"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4161\/mabs.22771","volume":"5","author":"Klein","year":"2013","journal-title":"MAbs"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"814064","DOI":"10.3389\/fimmu.2022.814064","volume":"13","author":"Torres","year":"2022","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40263-021-00895-w","volume":"36","author":"Yu","year":"2022","journal-title":"CNS Drugs"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s40265-021-01650-7","volume":"82","author":"Kang","year":"2022","journal-title":"Drugs"},{"key":"ref19","unstructured":"Kesimpta (ofatumumab) [prescribing information]. Novartis Pharmaceuticals Corporation. Available from: https:\/\/www.novartis.com\/us-en\/sites\/novartis_us\/files\/kesimpta.pdf. revised April 2024"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1177\/13524585211044479","volume":"28","author":"Bar-Or","year":"2022","journal-title":"Mult Scler"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1212\/WNL.0000000000000125","volume":"82","author":"Sorensen","year":"2014","journal-title":"Neurology"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e1805","DOI":"10.1212\/WNL.0000000000005516","volume":"90","author":"Bar-Or","year":"2018","journal-title":"Neurology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1002\/art.27524","volume":"62","author":"\u00d8stergaard","year":"2010","journal-title":"Arthritis Rheum"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.3899\/jrheum.121118","volume":"40","author":"Kurrasch","year":"2013","journal-title":"J Rheumatol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1056\/NEJMoa1917246","volume":"383","author":"Hauser","year":"2020","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1177\/13524585211055934","volume":"28","author":"Kira","year":"2022","journal-title":"Mult Scler"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1177\/13524585231195346","volume":"29","author":"Hauser","year":"2023","journal-title":"Mult Scler J"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1606468","volume":"376","author":"Montalban","year":"2017","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa1601277","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e1854","DOI":"10.1212\/WNL.0000000000010376","volume":"95","author":"Hauser","year":"2020","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.2217\/cer-2020-0122","volume":"9","author":"Samjoo","year":"2020","journal-title":"J Comp Eff Res"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1177\/13524585221078825","volume":"28","author":"G\u00e4rtner","year":"2022","journal-title":"Mult Scler"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"11795735211037785","DOI":"10.1177\/11795735211037785","volume":"13","author":"Kelsey","year":"2021","journal-title":"J Cent Nerv Syst Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000203074","author":"Bar-Or","year":"2023","journal-title":"Neurology"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s40263-022-00965-7","volume":"36","author":"Freeman","year":"2022","journal-title":"CNS Drugs"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11940-021-00677-1","volume":"23","author":"Simpson","year":"2021","journal-title":"Curr Treat Options Neurol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3390\/pharmaceutics16010120","volume":"16","author":"Lee","year":"2024","journal-title":"Pharmaceutics"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Pardo G, Hauser SL, Bar-Or A, et al. Longer-term (up to 6 Years) efficacy of ofatumumab in people with recently diagnosed and treatment-na\u00efve relapsing multiple sclerosis. Oral presentation at the American Academy of Neurology (AAN) 2024 Annual Meeting. 2024; Denver, CO.","DOI":"10.1212\/WNL.0000000000206274"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Wiendl H, Hauser SL, Nicholas J, et al. Longer-term safety and efficacy of ofatumumab in people with relapsing multiple sclerosis for up to 6 years. Poster presentation at the American Academy of Neurology (AAN) 2024 Annual Meeting. 2024; Denver, CO.","DOI":"10.1212\/WNL.0000000000205570"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/13696998.2022.2151270","volume":"26","author":"Vudumula","year":"2023","journal-title":"J Med Econ"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/13696998.2022.2161746","volume":"26","author":"Montgomery","year":"2023","journal-title":"J Med Econ"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s41669-022-00363-1","volume":"6","author":"Baharnoori","year":"2022","journal-title":"Pharmacoecon Open"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e220175","DOI":"10.57264\/cer-2022-0175","volume":"12","author":"Bhan","year":"2023","journal-title":"J Comp Eff Res"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.jval.2022.09.381","volume":"25","author":"Gon\u00e7alves","year":"2022","journal-title":"Value Health"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e2319766","DOI":"10.1001\/jamanetworkopen.2023.19766","volume":"6","author":"Januel","year":"2023","journal-title":"JAMA Network Open"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"103153","DOI":"10.1016\/j.msard.2021.103153","volume":"55","author":"Klineova","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"103729","DOI":"10.1016\/j.msard.2022.103729","volume":"60","author":"Bajwa","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1177\/13524585231185246","volume":"29","author":"Klineova","year":"2023","journal-title":"Mult Scler"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"104965","DOI":"10.1016\/j.msard.2023.104965","volume":"79","author":"Algu","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s40120-022-00341-z","volume":"11","author":"Cross","year":"2022","journal-title":"Neurol Ther"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"980526","DOI":"10.3389\/fimmu.2022.980526","volume":"13","author":"Faissner","year":"2022","journal-title":"Front Immunol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"102777","DOI":"10.1016\/j.msard.2021.102777","volume":"49","author":"Flores-Gonzalez","year":"2021","journal-title":"Mult Scler Relat Disord"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/vaccines10122167","volume":"10","author":"Ziemssen","year":"2022","journal-title":"Vaccines"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/vaccines11050978","volume":"11","author":"Ziemssen","year":"2023","journal-title":"Vaccines"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.reprotox.2021.12.006","volume":"108","author":"Bellot","year":"2022","journal-title":"Reprod Toxicol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1212\/WNL.0000000000202940","volume":"100","author":"Bove","year":"2023","journal-title":"Neurology"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.98.18_supplement.3377","volume":"98","author":"Hellwig","year":"2022","journal-title":"Neurology"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1177\/13524585211055593","volume":"28","author":"Rolfes","year":"2022","journal-title":"Mult Scler"}],"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/98293","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/98293","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T02:01:07Z","timestamp":1733968867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/profile-of-ofatumumab-in-the-treatment-of-multiple-sclerosis-design-de-peer-reviewed-fulltext-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":58,"URL":"https:\/\/doi.org\/10.2147\/dddt.s315174","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12]]}}}